PathMaker Neurosystems Announces Receipt of NIH Grant For Application of its Non-Invasive Neuromodulation Technology to Amyotrophic Lateral Sclerosis (ALS)
September 20, 2021 13:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 20, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Welcomes Healthcare Veteran Terri Bresenham to Board of Directors
July 15, 2020 07:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, July 15, 2020 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive technology for the...
PathMaker Neurosystems Appoints Medtech Industry Veteran Hooman Hakami as Chairman of Company’s Board of Directors
May 14, 2020 07:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, May 14, 2020 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment...